Back

Sodium–glucose co-transporter 2 inhibitors in heart failure

European Heart Journal - Cardiovascular Pharmacotherapy

9 February 2021
Organised by: Logo
Read full article
ESC Journals

Contributors

Giuseppe M C Rosano
Giuseppe M C Rosano

Author

St Georges Medical School London , United Kingdom of Great Britain & Northern Ireland

Cristiana Vitale
Cristiana Vitale

Author

Gianluigi Savarese
Gianluigi Savarese

Author

You may be interested in
thumbnail
Congress Session
Diabetes, obesity, and heart failure
19 May 2025
thumbnail
Congress Presentation
Impact of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in cancer patients: a systematic review and meta-analysis of heart failure hospitalisation and mortality.
26 April 2024
thumbnail
Congress Session
The power of now: a focus on SGLT2 inhibitors for heart failure in the hospital
17 May 2025
thumbnail
Congress Presentation
Empagliflozin in heart failure with preserved ejection fraction: decoding its molecular mechanism of action using artificial intelligence
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources